Literature DB >> 31352588

Identification of Biomarkers Related to Neuropathic Pain Induced by Peripheral Nerve Injury.

Chun-Guo Zhang1, Hong-Quan Wan2, Ke-Ning Ma1, Shu-Xin Luan3, He Li4.   

Abstract

Our study aimed to explore the molecular mechanisms and novel target genes of neuropathic pain via bioinformatics analysis. Gene expression profiling of GSE30691 which was consisted of sciatic nerve lesion and sham control samples at 3 days, 7 days, 21 days, and 40 days (D3, D7, D21, and D40) after injury were downloaded from Gene Expression Omnibus. Differentially expressed genes (DEGs) were identified for all the four time points. Overlapped DEGs for all the four time points were used for functional and weighted co-expression modular analysis. Afterwards, protein-protein interaction (PPI) network was analyzed by MCODE (Molecular Complex Detection) and BiNGO. Pathway network was constructed according to the enriched pathways of PPI network and relevant pathways selected from the Comparative Toxicogenomics Database. There were 355 overlapped DEGs for all the four time points. Two co-expression modules had significant positive correlations with disease. The top ten hub DEGs in the PPI network were Fos, Tp53, Csk, Map2k2, Stat3, Ccl2, Pxn, Tgfb1, Notch1, and Prkacb. Fos, Dusp1, Tp53, Tgfb1, and Map2k2 participated in MAPK signaling pathway, while Csk participated in chemokine signaling pathway. The expressions of Fos, Tp53, Csk, and Map2k2 were significantly increased at D3. Tp53, Csk, and Map2k2 continued overexpressing until at D7, and an elevated tendency in Csk expression could be observed until at D21. The expression of Fos reached up to the highest at D40. Fos, Tp53, Csk, and Map2k2 might be the potential biomarkers related to neuropathic pain.

Entities:  

Keywords:  Co-expression module; Neuropathic pain; Potential biomarkers

Mesh:

Substances:

Year:  2019        PMID: 31352588     DOI: 10.1007/s12031-019-01322-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Effect of normalization on significance testing for oligonucleotide microarrays.

Authors:  Rudolph S Parrish; Horace J Spencer
Journal:  J Biopharm Stat       Date:  2004-08       Impact factor: 1.051

Review 2.  Chemokines and cytokines in neuroinflammation leading to neuropathic pain.

Authors:  Norikazu Kiguchi; Yuka Kobayashi; Shiroh Kishioka
Journal:  Curr Opin Pharmacol       Date:  2011-10-21       Impact factor: 5.547

3.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 4.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

Review 5.  Chronic pain after surgery: pathophysiology, risk factors and prevention.

Authors:  Danielle Reddi; Natasha Curran
Journal:  Postgrad Med J       Date:  2014-02-26       Impact factor: 2.401

Review 6.  Neuropathic pain: a maladaptive response of the nervous system to damage.

Authors:  Michael Costigan; Joachim Scholz; Clifford J Woolf
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

Review 7.  MAP kinase and pain.

Authors:  Ru-Rong Ji; Robert W Gereau; Marzia Malcangio; Gary R Strichartz
Journal:  Brain Res Rev       Date:  2008-12-25

8.  Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis.

Authors:  Shannon D Shields; William A Eckert; Allan I Basbaum
Journal:  J Pain       Date:  2003-10       Impact factor: 5.820

9.  A rapamycin-sensitive signaling pathway is essential for the full expression of persistent pain states.

Authors:  Sandrine M Géranton; Lydia Jiménez-Díaz; Carole Torsney; Keri K Tochiki; Sarah A Stuart; J Lianne Leith; Bridget M Lumb; Stephen P Hunt
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

10.  RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications.

Authors:  Lei Wang; Chenlong Cao; Qibin Ma; Qiaoying Zeng; Haifeng Wang; Zhihao Cheng; Genfeng Zhu; Ji Qi; Hong Ma; Hai Nian; Yingxiang Wang
Journal:  BMC Plant Biol       Date:  2014-06-17       Impact factor: 4.215

View more
  1 in total

1.  Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain.

Authors:  Kord M Kober; Man-Cheung Lee; Adam Olshen; Yvette P Conley; Marina Sirota; Michael Keiser; Marilyn J Hammer; Gary Abrams; Mark Schumacher; Jon D Levine; Christine Miaskowski
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.